APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

HIV Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global HIV Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173998830320 December 2025187 pages

Choose your research edition.

Industry ResearchHIV Vaccines Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal HIV Vaccines Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal HIV Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HIV Vaccines Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal HIV Vaccines Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global HIV Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for HIV Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for HIV Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for HIV Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for HIV Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of HIV Vaccines include Sanofi, Glaxosmithkline, Paxvax, Janssen Global Services, Inovio Pharmaceuticals, Geovax, Genecure, Bionor Pharma and Argos Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global HIV Vaccines market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of HIV Vaccines and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents HIV Vaccines revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the HIV Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

HIV Vaccines Segment by Company

Sanofi

Glaxosmithkline

Paxvax

Janssen Global Services

Inovio Pharmaceuticals

Geovax

Genecure

Bionor Pharma

Argos Therapeutics

HIV Vaccines Segment by Type

Phase I

Phase II

Phase III

HIV Vaccines Segment by Application

Research Institute

Others

HIV Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HIV Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HIV Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HIV Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of HIV Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global HIV Vaccines industry.

Chapter 3: Detailed analysis of HIV Vaccines companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HIV Vaccinesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global HIV Vaccines Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Phase I Table 3. Key Players of Phase II Table 4. Key Players of Phase III Table 4. Global HIV Vaccines Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Research Institute Table 6. Key Players of Others Table 7. Global HIV Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global HIV Vaccines Market Size by Region (2021-2026) & (US$ Million) Table 9. Global HIV Vaccines Market Share by Region (2021-2026) Table 10. Global HIV Vaccines Market Size by Region (2027-2032) & (US$ Million) Table 11. Global HIV Vaccines Market Share by Region (2027-2032) Table 12. HIV Vaccines Industry Trends Table 13. HIV Vaccines Industry Drivers Table 14. HIV Vaccines Industry Opportunities and Challenges Table 15. HIV Vaccines Industry Restraints Table 16. Global HIV Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 17. Global HIV Vaccines Revenue Market Share by Company (2021-2026) Table 18. Global HIV Vaccines Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global HIV Vaccines Key Company Head Office and Area Served Table 20. Global HIV Vaccines Company, Product Type & Application Table 21. Global HIV Vaccines Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global HIV Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global HIV Vaccines Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global HIV Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 26. Global HIV Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 27. Global HIV Vaccines Revenue Market Share by Type (2021-2026) Table 28. Global HIV Vaccines Revenue Market Share by Type (2027-2032) Table 29. Global HIV Vaccines Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global HIV Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 31. Global HIV Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 32. Global HIV Vaccines Revenue Market Share by Application (2021-2026) Table 33. Global HIV Vaccines Revenue Market Share by Application (2027-2032) Table 34. Sanofi Company Information Table 35. Sanofi Business Overview Table 36. Sanofi HIV Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Sanofi HIV Vaccines Product Portfolio Table 38. Sanofi Recent Development Table 39. Glaxosmithkline Company Information Table 40. Glaxosmithkline Business Overview Table 41. Glaxosmithkline HIV Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Glaxosmithkline HIV Vaccines Product Portfolio Table 43. Glaxosmithkline Recent Development Table 44. Paxvax Company Information Table 45. Paxvax Business Overview Table 46. Paxvax HIV Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Paxvax HIV Vaccines Product Portfolio Table 48. Paxvax Recent Development Table 49. Janssen Global Services Company Information Table 50. Janssen Global Services Business Overview Table 51. Janssen Global Services HIV Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Janssen Global Services HIV Vaccines Product Portfolio Table 53. Janssen Global Services Recent Development Table 54. Inovio Pharmaceuticals Company Information Table 55. Inovio Pharmaceuticals Business Overview Table 56. Inovio Pharmaceuticals HIV Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Inovio Pharmaceuticals HIV Vaccines Product Portfolio Table 58. Inovio Pharmaceuticals Recent Development Table 59. Geovax Company Information Table 60. Geovax Business Overview Table 61. Geovax HIV Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Geovax HIV Vaccines Product Portfolio Table 63. Geovax Recent Development Table 64. Genecure Company Information Table 65. Genecure Business Overview Table 66. Genecure HIV Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Genecure HIV Vaccines Product Portfolio Table 68. Genecure Recent Development Table 69. Bionor Pharma Company Information Table 70. Bionor Pharma Business Overview Table 71. Bionor Pharma HIV Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Bionor Pharma HIV Vaccines Product Portfolio Table 73. Bionor Pharma Recent Development Table 74. Argos Therapeutics Company Information Table 75. Argos Therapeutics Business Overview Table 76. Argos Therapeutics HIV Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Argos Therapeutics HIV Vaccines Product Portfolio Table 78. Argos Therapeutics Recent Development Table 79. North America HIV Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 80. North America HIV Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 81. North America HIV Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 82. North America HIV Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 83. North America HIV Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. North America HIV Vaccines Market Size by Country (2021-2026) Table 85. North America HIV Vaccines Market Size by Country (2027-2032) Table 86. Europe HIV Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 87. Europe HIV Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 88. Europe HIV Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 89. Europe HIV Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 90. Europe HIV Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. Europe HIV Vaccines Market Size by Country (2021-2026) Table 92. Europe HIV Vaccines Market Size by Country (2027-2032) Table 93. China HIV Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 94. China HIV Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 95. China HIV Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 96. China HIV Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 97. Asia HIV Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 98. Asia HIV Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 99. Asia HIV Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 100. Asia HIV Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 101. Asia HIV Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Asia HIV Vaccines Market Size by Country (2021-2026) Table 103. Asia HIV Vaccines Market Size by Country (2027-2032) Table 104. South America, Middle East & Africa HIV Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 105. South America, Middle East & Africa HIV Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 106. South America, Middle East & Africa HIV Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 107. South America, Middle East & Africa HIV Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 108. South America, Middle East & Africa HIV Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. South America, Middle East & Africa HIV Vaccines Market Size by Country (2021-2026) Table 110. South America, Middle East & Africa HIV Vaccines Market Size by Country (2027-2032) Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. HIV Vaccines Product Image Figure 2. Global HIV Vaccines Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global HIV Vaccines Market Share by Type: 2025 VS 2032 Figure 4. Phase I Image Figure 5. Phase II Image Figure 6. Phase III Image Figure 7. Global HIV Vaccines Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global HIV Vaccines Market Share by Application: 2025 VS 2032 Figure 9. Research Institute Image Figure 10. Others Image Figure 11. Global HIV Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 13. Global HIV Vaccines Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global HIV Vaccines Market Share by Players in 2025 Figure 16. Global Top 5 and 10 HIV Vaccines Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global HIV Vaccines Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global HIV Vaccines Revenue Market Share by Type (2021-2032) Figure 20. Global HIV Vaccines Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global HIV Vaccines Revenue Market Share by Application (2021-2032) Figure 22. North America HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 23. North America HIV Vaccines Market Share by Type (2021-2032) Figure 24. North America HIV Vaccines Market Share by Application (2021-2032) Figure 25. North America HIV Vaccines Market Share by Country (2021-2032) Figure 26. United States HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 27. Canada HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 28. Mexico HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 29. Europe HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 30. Europe HIV Vaccines Market Share by Type (2021-2032) Figure 31. Europe HIV Vaccines Market Share by Application (2021-2032) Figure 32. Europe HIV Vaccines Market Share by Country (2021-2032) Figure 33. Germany HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 34. France HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 35. U.K. HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 36. Italy HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 37. Russia HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 39. China HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 40. China HIV Vaccines Market Share by Type (2021-2032) Figure 41. China HIV Vaccines Market Share by Application (2021-2032) Figure 42. Asia HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 43. Asia HIV Vaccines Market Share by Type (2021-2032) Figure 44. Asia HIV Vaccines Market Share by Application (2021-2032) Figure 45. Asia HIV Vaccines Market Share by Country (2021-2032) Figure 46. Japan HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 47. South Korea HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 50. India HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 51. Australia HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa HIV Vaccines Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa HIV Vaccines Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa HIV Vaccines Market Share by Country (2021-2032) Figure 56. Brazil HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 57. South Africa HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 59. Turkey HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 60. Argentina HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 61. UAE HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 62. Egypt HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 63. Chile HIV Vaccines Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Phase I
  • Phase II
  • Phase III
Applications
  • Research Institute
  • Others
Companies covered
  • Sanofi
  • Glaxosmithkline
  • Paxvax
  • Janssen Global Services
  • Inovio Pharmaceuticals
  • Geovax
  • Genecure
  • Bionor Pharma
  • Argos Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global HIV Vaccines Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Phase I
  5. 1.2.3 Phase II
  6. 1.2.4 Phase III
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global HIV Vaccines Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Research Institute
  10. 1.3.3 Others
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global HIV Vaccines Growth Trends by Region
  13. 1.5.1 Global HIV Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 HIV Vaccines Market Size by Region (2021-2026)
  15. 1.5.3 HIV Vaccines Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global HIV Vaccines Market Dynamics
  1. 2.1 HIV Vaccines Industry Trends
  2. 2.2 HIV Vaccines Industry Drivers
  3. 2.3 HIV Vaccines Industry Opportunities and Challenges
  4. 2.4 HIV Vaccines Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global HIV Vaccines Revenue by Company (2021-2026)
  2. 3.2 Global HIV Vaccines Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global HIV Vaccines Key Company Head office and Area Served
  4. 3.4 Global HIV Vaccines Company, Product Type & Application
  5. 3.5 Global HIV Vaccines Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global HIV Vaccines Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 HIV Vaccines Players Market Share by Revenue in 2025
  9. 3.6.3 2025 HIV Vaccines Tier 1, Tier 2, and Tier 3
4 HIV Vaccines Market by Type
  1. 4.1 Global HIV Vaccines Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global HIV Vaccines Market Size by Type (2021-2032)
  3. 4.3 Global HIV Vaccines Market Size Share by Type (2021-2032)
5 HIV Vaccines Market by Application
  1. 5.1 Global HIV Vaccines Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global HIV Vaccines Market Size by Application (2021-2032)
  3. 5.3 Global HIV Vaccines Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi HIV Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Sanofi HIV Vaccines Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Glaxosmithkline
  8. 6.2.1 Glaxosmithkline Company Information
  9. 6.2.2 Glaxosmithkline Business Overview
  10. 6.2.3 Glaxosmithkline HIV Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Glaxosmithkline HIV Vaccines Product Portfolio
  12. 6.2.5 Glaxosmithkline Recent Developments
  13. 6.3 Paxvax
  14. 6.3.1 Paxvax Company Information
  15. 6.3.2 Paxvax Business Overview
  16. 6.3.3 Paxvax HIV Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Paxvax HIV Vaccines Product Portfolio
  18. 6.3.5 Paxvax Recent Developments
  19. 6.4 Janssen Global Services
  20. 6.4.1 Janssen Global Services Company Information
  21. 6.4.2 Janssen Global Services Business Overview
  22. 6.4.3 Janssen Global Services HIV Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Janssen Global Services HIV Vaccines Product Portfolio
  24. 6.4.5 Janssen Global Services Recent Developments
  25. 6.5 Inovio Pharmaceuticals
  26. 6.5.1 Inovio Pharmaceuticals Company Information
  27. 6.5.2 Inovio Pharmaceuticals Business Overview
  28. 6.5.3 Inovio Pharmaceuticals HIV Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Inovio Pharmaceuticals HIV Vaccines Product Portfolio
  30. 6.5.5 Inovio Pharmaceuticals Recent Developments
  31. 6.6 Geovax
  32. 6.6.1 Geovax Company Information
  33. 6.6.2 Geovax Business Overview
  34. 6.6.3 Geovax HIV Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Geovax HIV Vaccines Product Portfolio
  36. 6.6.5 Geovax Recent Developments
  37. 6.7 Genecure
  38. 6.7.1 Genecure Company Information
  39. 6.7.2 Genecure Business Overview
  40. 6.7.3 Genecure HIV Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Genecure HIV Vaccines Product Portfolio
  42. 6.7.5 Genecure Recent Developments
  43. 6.8 Bionor Pharma
  44. 6.8.1 Bionor Pharma Company Information
  45. 6.8.2 Bionor Pharma Business Overview
  46. 6.8.3 Bionor Pharma HIV Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Bionor Pharma HIV Vaccines Product Portfolio
  48. 6.8.5 Bionor Pharma Recent Developments
  49. 6.9 Argos Therapeutics
  50. 6.9.1 Argos Therapeutics Company Information
  51. 6.9.2 Argos Therapeutics Business Overview
  52. 6.9.3 Argos Therapeutics HIV Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Argos Therapeutics HIV Vaccines Product Portfolio
  54. 6.9.5 Argos Therapeutics Recent Developments
7 North America
  1. 7.1 North America HIV Vaccines Market Size (2021-2032)
  2. 7.2 North America HIV Vaccines Market Size by Type
  3. 7.2.1 North America HIV Vaccines Market Size by Type (2021-2026)
  4. 7.2.2 North America HIV Vaccines Market Size by Type (2027-2032)
  5. 7.2.3 North America HIV Vaccines Market Share by Type (2021-2032)
  6. 7.3 North America HIV Vaccines Market Size by Application
  7. 7.3.1 North America HIV Vaccines Market Size by Application (2021-2026)
  8. 7.3.2 North America HIV Vaccines Market Size by Application (2027-2032)
  9. 7.3.3 North America HIV Vaccines Market Share by Application (2021-2032)
  10. 7.4 North America HIV Vaccines Market Size by Country
  11. 7.4.1 North America HIV Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America HIV Vaccines Market Size by Country (2021-2026)
  13. 7.4.3 North America HIV Vaccines Market Size by Country (2027-2032)
  14. 7.4.4 North America HIV Vaccines Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe HIV Vaccines Market Size (2021-2032)
  2. 8.2 Europe HIV Vaccines Market Size by Type
  3. 8.2.1 Europe HIV Vaccines Market Size by Type (2021-2026)
  4. 8.2.2 Europe HIV Vaccines Market Size by Type (2027-2032)
  5. 8.2.3 Europe HIV Vaccines Market Share by Type (2021-2032)
  6. 8.3 Europe HIV Vaccines Market Size by Application
  7. 8.3.1 Europe HIV Vaccines Market Size by Application (2021-2026)
  8. 8.3.2 Europe HIV Vaccines Market Size by Application (2027-2032)
  9. 8.3.3 Europe HIV Vaccines Market Share by Application (2021-2032)
  10. 8.4 Europe HIV Vaccines Market Size by Country
  11. 8.4.1 Europe HIV Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe HIV Vaccines Market Size by Country (2021-2026)
  13. 8.4.3 Europe HIV Vaccines Market Size by Country (2027-2032)
  14. 8.4.4 Europe HIV Vaccines Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China HIV Vaccines Market Size (2021-2032)
  2. 9.2 China HIV Vaccines Market Size by Type
  3. 9.2.1 China HIV Vaccines Market Size by Type (2021-2026)
  4. 9.2.2 China HIV Vaccines Market Size by Type (2027-2032)
  5. 9.2.3 China HIV Vaccines Market Share by Type (2021-2032)
  6. 9.3 China HIV Vaccines Market Size by Application
  7. 9.3.1 China HIV Vaccines Market Size by Application (2021-2026)
  8. 9.3.2 China HIV Vaccines Market Size by Application (2027-2032)
  9. 9.3.3 China HIV Vaccines Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia HIV Vaccines Market Size (2021-2032)
  2. 10.2 Asia HIV Vaccines Market Size by Type
  3. 10.2.1 Asia HIV Vaccines Market Size by Type (2021-2026)
  4. 10.2.2 Asia HIV Vaccines Market Size by Type (2027-2032)
  5. 10.2.3 Asia HIV Vaccines Market Share by Type (2021-2032)
  6. 10.3 Asia HIV Vaccines Market Size by Application
  7. 10.3.1 Asia HIV Vaccines Market Size by Application (2021-2026)
  8. 10.3.2 Asia HIV Vaccines Market Size by Application (2027-2032)
  9. 10.3.3 Asia HIV Vaccines Market Share by Application (2021-2032)
  10. 10.4 Asia HIV Vaccines Market Size by Country
  11. 10.4.1 Asia HIV Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia HIV Vaccines Market Size by Country (2021-2026)
  13. 10.4.3 Asia HIV Vaccines Market Size by Country (2027-2032)
  14. 10.4.4 Asia HIV Vaccines Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa HIV Vaccines Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa HIV Vaccines Market Size by Type
  3. 11.2.1 South America, Middle East & Africa HIV Vaccines Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa HIV Vaccines Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa HIV Vaccines Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa HIV Vaccines Market Size by Application
  7. 11.3.1 South America, Middle East & Africa HIV Vaccines Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa HIV Vaccines Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa HIV Vaccines Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa HIV Vaccines Market Size by Country
  11. 11.4.1 South America, Middle East & Africa HIV Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa HIV Vaccines Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa HIV Vaccines Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa HIV Vaccines Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst